[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f7Txa1IhRdo0CX97PuQUSSz6QwiajBViyD8FurC102vg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":31,"phaseBuckets":32,"rows":39},"Jhpiego",[4],32,false,4,0,87678,28,[13,15,17,20,22,25,27,29],{"name":14,"count":8},"Contraception",{"name":16,"count":8},"Contraceptive Usage",{"name":18,"count":19},"Malaria in Pregnancy",3,{"name":21,"count":19},"Cervical Cancer",{"name":23,"count":24},"Cervical Dysplasia",2,{"name":26,"count":24},"Stillbirth",{"name":28,"count":24},"Uncomplicated Malaria",{"name":30,"count":24},"Integrated Care",[],[33,34,35,36,37,38],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[40,67,85,111,129,153],{"intervention":41,"totalTrials":42,"cells":43},"artemether lumefantrine",1,{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":65},{"trials":45,"activeCount":9},[],{"trials":47,"activeCount":9},[],{"trials":49,"activeCount":9},[],{"trials":51,"activeCount":9},[],{"trials":53,"activeCount":9},[54],{"nctId":55,"briefTitle":56,"status":57,"phases":58,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":63},"NCT04767191","Malaria Therapeutic Efficacy Study (TES) Kenya","COMPLETED",[37],"2022-12-18","2021-03-15",400,[28],[41,64],"dihydroartemisinin piperaquine",{"trials":66,"activeCount":9},[],{"intervention":64,"totalTrials":42,"cells":68},{"EARLY_PHASE1":69,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":83},{"trials":70,"activeCount":9},[],{"trials":72,"activeCount":9},[],{"trials":74,"activeCount":9},[],{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[79],{"nctId":55,"briefTitle":56,"status":57,"phases":80,"primaryCompletion":59,"completion":59,"start":60,"enrollment":61,"conditions":81,"interventions":82},[37],[28],[41,64],{"trials":84,"activeCount":9},[],{"intervention":86,"totalTrials":42,"cells":87},"artemether-lumefantrine",{"EARLY_PHASE1":88,"PHASE1":90,"PHASE2":92,"PHASE3":94,"PHASE4":96,"NA":109},{"trials":89,"activeCount":9},[],{"trials":91,"activeCount":9},[],{"trials":93,"activeCount":9},[],{"trials":95,"activeCount":9},[],{"trials":97,"activeCount":9},[98],{"nctId":99,"briefTitle":100,"status":57,"phases":101,"primaryCompletion":102,"completion":103,"start":104,"enrollment":105,"conditions":106,"interventions":107},"NCT04767217","Malaria Therapeutic Efficacy Study, Rwanda",[37],"2023-12-08","2024-01-31","2021-06-14",528,[28],[86,108],"dihydroartemisinin-piperaquine",{"trials":110,"activeCount":9},[],{"intervention":108,"totalTrials":42,"cells":112},{"EARLY_PHASE1":113,"PHASE1":115,"PHASE2":117,"PHASE3":119,"PHASE4":121,"NA":127},{"trials":114,"activeCount":9},[],{"trials":116,"activeCount":9},[],{"trials":118,"activeCount":9},[],{"trials":120,"activeCount":9},[],{"trials":122,"activeCount":9},[123],{"nctId":99,"briefTitle":100,"status":57,"phases":124,"primaryCompletion":102,"completion":103,"start":104,"enrollment":105,"conditions":125,"interventions":126},[37],[28],[86,108],{"trials":128,"activeCount":9},[],{"intervention":130,"totalTrials":42,"cells":131},"HPV Vaccine",{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":136,"PHASE3":138,"PHASE4":140,"NA":142},{"trials":133,"activeCount":9},[],{"trials":135,"activeCount":9},[],{"trials":137,"activeCount":9},[],{"trials":139,"activeCount":9},[],{"trials":141,"activeCount":9},[],{"trials":143,"activeCount":9},[144],{"nctId":145,"briefTitle":146,"status":57,"phases":147,"primaryCompletion":148,"completion":148,"start":149,"enrollment":150,"conditions":151,"interventions":152},"NCT01096134","Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention",[38],"2012-11","2011-01",8000,[21],[130],{"intervention":154,"totalTrials":42,"cells":155},"oxytocin and misoprostol",{"EARLY_PHASE1":156,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":164,"NA":166},{"trials":157,"activeCount":9},[],{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[],{"trials":163,"activeCount":9},[],{"trials":165,"activeCount":9},[],{"trials":167,"activeCount":9},[168],{"nctId":169,"briefTitle":170,"status":57,"phases":171,"primaryCompletion":172,"completion":172,"start":173,"enrollment":174,"conditions":175,"interventions":178},"NCT03254628","Saving Lives at Birth in Uganda: Building and Sustaining Capacity of Frontline Health Workers - A Program Evaluation",[38],"2016-12-31","2014-11-14",3440,[176,177],"Postpartum Hemorrhage","Neonatal Asphyxia",[154]]